The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic-Reference-Cited by-同舟云学术

The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

Published:2020-11 Issue:5 Volume:83 Page:1523-1526
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Syed Maha N.,Shin Daniel B.,Wan Marilyn T.,Winthrop Kevin L.,Gelfand Joel M.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: a meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic;Wan;J Am Acad Dermatol,2020

2. IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS;Yannam;J Neuroimmune Pharmacol,2012

3. Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review;Kamata;Int J Mol Sci,2020

4. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during red-zone declaration;Damiani;Dermatol Ther,2020

5. Improvement of SARS-CoV2 symptoms following guselkumab injection in a psoriatic patient;Benhadou;J Eur Acad Dermatol Venereol,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Age-Related Characteristic Genes Involved in Severe COVID-19 Infection Among Elderly Patients Using Machine Learning and Immune Cell Infiltration Analysis;Biochemical Genetics;2024-04-24

2. Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis;Inflammatory Bowel Diseases;2024-03-01

3. Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339);Biomedicine & Pharmacotherapy;2024-01

4. Identification of Age-Related Characteristic Genes Involved in Severe COVID-19 Infection Among Elderly Patients using Machine Learning and Immune Cell Infiltration Analysis;2023-05-16

5. The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness;Current Dermatology Reports;2023-04-03